Zobrazeno 1 - 10
of 366
pro vyhledávání: '"William H, Wehrmacher"'
Autor:
William H. Wehrmacher
Publikováno v:
Postgraduate medicine. 85(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3769a18de287b6f5d90b3b4f6cfa1a40
https://pubmed.ncbi.nlm.nih.gov/27238243
https://pubmed.ncbi.nlm.nih.gov/27238243
Autor:
William H. Wehrmacher, Marjan Mujib, Michel White, James B. Young, Philippe Meyer, Inmaculada Aban, Ali Ahmed, Thomas E. Love, Anna Nozza
Publikováno v:
The American Journal of Cardiology. 102:1681-1686
In the Digitalis Investigation Group trial, digoxin-associated decrease in the combined end point of heart failure (HF) hospitalization or HF mortality was significant in systolic but not in diastolic HF. To assess whether this apparent disparity cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c6acf71ae810b221ffd379b92cae4b8
https://doi.org/10.1016/j.amjcard.2008.05.068
https://doi.org/10.1016/j.amjcard.2008.05.068
Publikováno v:
Comprehensive Therapy. 33:231-236
Better recognition of primary pulmonary hypertension can produce better treatment by comprehensive therapists.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d19555d209e852f01c03f53a6b00235d
https://doi.org/10.1007/s12019-007-8017-4
https://doi.org/10.1007/s12019-007-8017-4
Publikováno v:
Comprehensive Therapy. 33:48-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cc8d948a3d596f60df7fab82624a92c
https://doi.org/10.1007/s12019-007-0001-5
https://doi.org/10.1007/s12019-007-0001-5
Publikováno v:
Comprehensive Therapy. 32:261-266
The advent of cyclooxygenase-2 inhibitors has been both a blessing and a curse for pain management. An in-depth understanding of the biological molecules in the arachidonic acid metabolism may alleviate pain without risk.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45852191db216304a5e453cc0acb3269
https://doi.org/10.1007/bf02698073
https://doi.org/10.1007/bf02698073
Publikováno v:
Comprehensive Therapy. 32:236-239
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most used medications in the world. Ordinarily considered to be safe and effective when used according to labeling instructions, their safety for patients with cardiovascular disease is now
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56852c354984337c04bebee2853df9fd
https://doi.org/10.1007/bf02698069
https://doi.org/10.1007/bf02698069
Publikováno v:
Comprehensive Therapy. 32:163-171
The porphyrias are inherited or acquired metabolic disorders caused by a partial deficiency in one of the enzymes of the heme biosynthetic pathway. Eight enzymes are utilized in the synthesis of heme. An enzyme defect in one of the last seven enzymes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b364ef460e521f3de2c47e9995285c6a
https://doi.org/10.1007/s12019-006-0007-4
https://doi.org/10.1007/s12019-006-0007-4
Autor:
Walter Jeske, Fred Leya, William H. Wehrmacher, Leslie Cho, Sohrab Mobarhan, Erwin Coyne, John F. Moran, Harry L. Messmore
Publikováno v:
Hematology/Oncology Clinics of North America. 19:87-117
Antiplatelet drugs in clinical use are discussed in terms of their mechanisms of action and the relevancy of that to the physiology of platelets and the pathophysiology of arterial thrombosis. Current clinical usage is outlined in detail for each dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e1b940678a650b2736449cc2c83997e
https://doi.org/10.1016/j.hoc.2004.09.004
https://doi.org/10.1016/j.hoc.2004.09.004
Publikováno v:
Comprehensive Therapy. 30:155-159
Women must now gain the phenomenal care justified by new biologic evidence and a comprehensive understanding of fundamental differences from men-that go well beyond secondary sexual characteristics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d21167d8a0d63b1d505b3a1de28eb75
https://doi.org/10.1007/s12019-004-0012-4
https://doi.org/10.1007/s12019-004-0012-4
Publikováno v:
Seminars in Thrombosis and Hemostasis. 30:81-88
The 87-year history of heparin began in 1916 when a 26-year-old medical student named Jay McLean startled his mentor William Howell, Professor of Physiology at Johns Hopkins University, by proclaiming that he had discovered "antithrombin." This disco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3936163b5f96456f2a11de85e025b36
https://doi.org/10.1055/s-2004-823006
https://doi.org/10.1055/s-2004-823006